Name: UMIN ID:
Unique ID issued by UMIN | UMIN000021247 |
---|---|
Receipt number | R000024483 |
Scientific Title | Tocilizumab treatment with reducing and stopping methotrexate in patients with rheumatoid arthritis in stable low disease activity-state |
Date of disclosure of the study information | 2016/07/22 |
Last modified on | 2019/09/06 14:07:52 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/02/29 14:54:43 | ||
2 | Update | 2016/05/25 15:49:16 | Name of primary person or sponsor Organization Date of disclosure of the study information |
|
3 | Update | 2016/05/25 18:00:24 | Date of disclosure of the study information |
|
4 | Update | 2016/06/30 15:17:38 | Date of disclosure of the study information |
|
5 | Update | 2016/07/13 16:43:09 | Date of disclosure of the study information |
|
6 | Update | 2016/07/27 16:56:05 | Key secondary outcomes Key secondary outcomes |
|
7 | Update | 2016/07/27 16:58:57 | Organization Organization Category of Funding Organization |
|
8 | Update | 2016/07/27 17:01:02 | Date of protocol fixation Anticipated trial start date |
|
9 | Update | 2016/12/22 17:53:27 | Recruitment status |
|
10 | Update | 2017/08/22 15:04:56 | Target sample size |
|
11 | Update | 2017/08/22 15:05:58 | Key secondary outcomes |
|
12 | Update | 2017/08/22 15:06:53 | Recruitment status |
|
13 | Update | 2019/09/06 14:00:51 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
14 | Update | 2019/09/06 14:07:24 | Recruitment status Date of IRB Last follow-up date |
|
15 | Update | 2019/09/06 14:07:52 | Publication of results Number of participants that the trial has enrolled |